Insights into disease and pharmacotherapy knowledge of Alzheimer's disease among community pharmacists: a cross-sectional study

dc.authoridAnmar Al-Taie / 0000-0002-2183-6830en_US
dc.authorscopusidAnmar Al-Taie / 57221579036en_US
dc.authorwosidAnmar Al-Taie / DTF-7591-2022en_US
dc.contributor.authorAl-Taie, Anmar
dc.contributor.authorYılmaz, Zekiye K.
dc.contributor.authorDahman, Hasan
dc.contributor.authorYardımcı, Turay
dc.date.accessioned2022-11-12T06:51:22Z
dc.date.available2022-11-12T06:51:22Z
dc.date.issued2022en_US
dc.departmentİstinye Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümüen_US
dc.description.abstractObjective To assess the knowledge level and awareness of Alzheimer's disease, including knowledge about the disease, pharmacotherapy, provision of patient education and associated factors among community pharmacists across Turkey and Northern Cyprus. Methods This was a descriptive, cross-sectional study conducted among community pharmacists working in Turkey (Group A) and Northern Cyprus (Group B). Disease and pharmacotherapy knowledge of AD were assessed using AD Knowledge Scale (ADKS), and drug treatment (KADT) scale, respectively. Results Both groups reported a moderate level of knowledge of AD, especially medically-oriented domains, with no significant difference regarding the mean ADKS domains (18.8 +/- 2.8 vs. 18.9 +/- 3.4; p = .98). Nevertheless, participants from both groups reported a good level of KADT knowledge about AD treatment (p = .03). Group A reported a statistically significant higher level of knowledge about drug interactions compared with Group B (54.6% vs. 45.8%; p = .01), and knowledge about proper information (79.6% vs. 31.8%; p = .02). There was a statistically significant KADT difference correlated with gender, those having a Master degree, more than 5 years of work experience, and those taking AD training courses. Conclusion There is still a lack of knowledge regarding AD reported by moderate ADKS score, especially in medically-oriented domains, which creates a barrier to early provision of care and preventing AD, noted with no difference among community pharmacists across Turkey and Northern Cyprus.en_US
dc.identifier.citationAl-Taie, A., Yilmaz, Z. K., Dahmanv, H., & Yardimci, T. (2022). Insights into disease and pharmacotherapy knowledge of Alzheimer’s disease among community pharmacists: a cross-sectional study. Current Medical Research and Opinion, (just-accepted), 1-23.en_US
dc.identifier.doi10.1080/03007995.2022.2129802en_US
dc.identifier.scopus2-s2.0-85139911288en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.urihttps://doi.org/10.1080/03007995.2022.2129802
dc.identifier.urihttps://hdl.handle.net/20.500.12713/3333
dc.identifier.wosWOS:000865692300001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorAl-Taie, Anmar
dc.language.isoenen_US
dc.publisherTAYLOR & FRANCIS LTDen_US
dc.relation.ispartofCURRENT MEDICAL RESEARCH AND OPINIONen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAlzheimer's Diseaseen_US
dc.subjectCommunity Pharmacistsen_US
dc.subjectGeriatricsen_US
dc.subjectKnowledgeen_US
dc.subjectTurkeyen_US
dc.titleInsights into disease and pharmacotherapy knowledge of Alzheimer's disease among community pharmacists: a cross-sectional studyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Insights into disease and pharmacotherapy knowledge of Alzheimer s disease among community pharmacists a cross sectional study.pdf
Boyut:
1.5 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: